AMRS / Is It Time to Buy This Year's Worst-Performing Growth Stocks?

WeWork, a prized startup just four years ago but now a micro-cap, and other penny stocks such as Amyris and Proterra are the latest focus of speculati more_horizontal

Amyris (NASDAQ: AMRS ) stock is rising higher on Friday with heavy trading after the biotechnology company filed for bankruptcy. AMRS stock is bounci more_horizontal

Synthetic biotechnology company Amyris filed for Chapter 11 bankruptcy protection as it restructures, leading its share price to drop more than 70% in more_horizontal

Amyris (NASDAQ: AMRS ) stock is falling on Thursday after the company filed for Chapter 11 bankruptcy protection. According to a press release from A more_horizontal

Cash-strapped specialty renewable products developer Amyris remains on life support by largest shareholder and creditor John Doerr. In recent months, more_horizontal

Not all low-priced stocks are appealing for investment, as some remain too unpredictable even at a lower buy-in price. This is a mixed bag and investo more_horizontal

The resignation of Amyris' CEO is likely to be viewed as a positive by many, but the implications of this are negative. Management turnover and the en more_horizontal

Earlier this month, cash-strapped specialty renewable products developer Amyris announced a strategic transformation program to improve the company's more_horizontal